BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38368754)

  • 1. SIMarker: Cellular similarity detection and its application to diagnosis and prognosis of liver cancer.
    Tong M; Luo S; Gu L; Wang X; Zhang Z; Liang C; Huang H; Lin Y; Huang J
    Comput Biol Med; 2024 Mar; 171():108113. PubMed ID: 38368754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients.
    Mustafa MG; Petersen JR; Ju H; Cicalese L; Snyder N; Haidacher SJ; Denner L; Elferink C
    Mol Cell Proteomics; 2013 Dec; 12(12):3640-52. PubMed ID: 24008390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
    Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factors linked to the molecular signatures in the development of hepatocellular carcinoma on a cirrhotic background.
    Motalebzadeh J; Eskandari E
    Med Oncol; 2021 Sep; 38(10):121. PubMed ID: 34468893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From genome sequencing to the discovery of potential biomarkers in liver disease.
    Oh S; Jo Y; Jung S; Yoon S; Yoo KH
    BMB Rep; 2020 Jun; 53(6):299-310. PubMed ID: 32475383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma.
    Song P; Tang Q; Feng X; Tang W
    Scand J Clin Lab Invest Suppl; 2016; 245():S70-6. PubMed ID: 27438343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel significant stage-specific differentially expressed genes in hepatocellular carcinoma.
    Sarathi A; Palaniappan A
    BMC Cancer; 2019 Jul; 19(1):663. PubMed ID: 31277598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs.
    Koduru SV; Leberfinger AN; Kawasawa YI; Mahajan M; Gusani NJ; Sanyal AJ; Ravnic DJ
    Sci Rep; 2018 May; 8(1):7967. PubMed ID: 29789629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and Diagnostic Significance of SDPR-Cavin-2 in Hepatocellular Carcinoma.
    Jing W; Luo P; Zhu M; Ai Q; Chai H; Tu J
    Cell Physiol Biochem; 2016; 39(3):950-60. PubMed ID: 27513662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
    Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
    Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets' RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules.
    Waqar W; Asghar S; Manzoor S
    PLoS One; 2021; 16(9):e0256739. PubMed ID: 34469466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of exosomal miR-18a and miR-222 levels in Egyptian patients with hepatic cirrhosis and hepatocellular carcinoma.
    Elghoroury EA; Abdelghaffar EE; Awadallah E; Kamel SA; Kandil D; Hassan EM; Hassan M; Kamel MM; Gomaa MM; Fathalla LA
    Int J Immunopathol Pharmacol; 2022; 36():3946320221097832. PubMed ID: 35467432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
    Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision pathology analysis of the development and progression of hepatocellular carcinoma: Implication for precision diagnosis of hepatocellular carcinoma.
    Ueno A; Masugi Y; Yamazaki K; Kurebayashi Y; Tsujikawa H; Effendi K; Ojima H; Sakamoto M
    Pathol Int; 2020 Mar; 70(3):140-154. PubMed ID: 31908112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.
    Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J
    Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ssDNA as a Noninvasive Indicator for the Diagnosis and Prognosis of Hepatocellular Carcinoma: An Exploratory Study.
    Zhao Q; Xu Y; Yuan D; Yang J; Wang Y; Shen G; Huang X
    Dis Markers; 2021; 2021():9958909. PubMed ID: 34394775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosis.
    Wu T; Fan R; Bai J; Yang Z; Qian YS; Du LT; Wang CY; Wang YC; Jiang GQ; Zheng D; Fan XT; Zheng B; Liu JF; Deng GH; Shen F; Hu HP; Ye YN; Zhang QZ; Zhang J; Gao YH; Xia J; Yan HD; Liang MF; Yu YL; Sun FM; Gao YJ; Sun J; Zhong CX; Wang Y; Wang H; Kong F; Chen JM; Wen H; Wu BM; Wang CX; Wu L; Hou JL; Liu XL; Wang HY; Chen L
    J Hematol Oncol; 2023 Jan; 16(1):1. PubMed ID: 36600307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings.
    Ao L; Zhang Z; Guan Q; Guo Y; Guo Y; Zhang J; Lv X; Huang H; Zhang H; Wang X; Guo Z
    Liver Int; 2018 Oct; 38(10):1812-1819. PubMed ID: 29682909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs as Plasma Biomarkers of Hepatocellular Carcinoma in Patients with Liver Cirrhosis-A Cross-Sectional Study.
    Zenlander R; Salter H; Gilg S; Eggertsen G; Stål P
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of preclinical hepatocellular carcinoma in patients with cirrhosis.
    Piva A; De Fazio C; Covini G; Tommasini M; Colombo M
    J Surg Oncol Suppl; 1993; 3():46-8. PubMed ID: 8389172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.